Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011854 (
type 1 diabetes
)
20,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Magnesium ions (Mg2+) are pivotal in the transfer, storage and utilization of energy; Mg2+ regulates and catalyzes some 300-odd enzyme systems in mammals. The intracellular level of free Mg2+ ([Mg2+]i) regulates intermediary metabolism, DNA and RNA synthesis and structure, cell growth, reproduction, and membrane structure. Mg2+ has numerous physiological roles among which are control of neuronal activity, cardiac excitability, neuromuscular transmission, muscular contraction, vasomotor tone, blood pressure and peripheral blood flow. Mg2+ modulates and controls cell Ca2+ entry and Ca2+ release from sarcoplasmic and endoplasmic reticular membranes. Since the turn of this century, there has been a steady and progressive decline of dietary Mg intake to where much of the Western World population is ingesting less than an optimum
RDA
. Geographic regions low in soil and water Mg demonstrate increased cardiovascular morbidity and mortality. Dietary deficiency of Mg2+ results in loss of cellular K+ and gain of cellular Na+ and calcium ions (Ca2+). Blood normally contains Mg2+ bound to proteins, Mg2+ complexed to small anion ligands and free ionized Mg2+ (IMg2+). Most clinical laboratories only now assess the total Mg, which consists of all three Mg fractions. Estimation of the IMg2+ level in serum or plasma by analysis of ultrafiltrates (complexed Mg + IMg2+) is somewhat unsatisfactory, as the methods employed do not distinguish the truly ionized form from Mg2+ bound to organic and inorganic anions. Because the levels of these ligands can vary significantly in numerous pathological states, it is desirable to directly measure the levels of IMg2+ in complex matrices such as whole blood, plasma and serum. Using novel ion selective electrodes (ISE's), we have found that there is virtually no difference in IMg2+, irrespective of whether one samples whole blood, plasma or serum. These data demonstrate that the mean concentration of IMg2+ in blood is about 600 mumoles/litre (0.54-0.65 mmol/L, 95% Cl); 65-72% of total Mg being free or biologically-active Mg2+. Use of the NOVA and KONE ISE's for IMg2+ on plasma and sera from patients with a variety of pathophysiologic and disease syndromes (e.g., long-term renal transplants, liver transplants, during and before cardiac surgery, ischemic heart disease [IHD], headaches, pregnancy, neonatal period, non-
insulin dependent diabetes
(NIDDM), end-stage renal disease [ESRD], hemodialyse [HEM], and continuous ambulatory peritoneal dialysis (CAPD), hypertension, myocardial infarction [AMI] and after excessive dietary intake of Mg), has revealed interesting data. The results indicate that long-term renal transplant patients, headache, pregnant, NIDDM, ESRD, HEM, CAPD, AMI, hypertensive, and IHD subjects exhibit, on the average significant depression in IMg2+ but not TMg. Use of 31P-NMR spectroscopy on red blood cells, from several of these disease states, to assess free intracellular Mg ([Mg2+]i demonstrates a high correlation (r = 0.5-0.8) between IMg2+ and [Mg2+]i. Increased dietary load of Mg, for only 6 days, in human volunteers, resulted in significant elevations in serum IMg2+ but not TMg. Correlations between the clinical course of several of the above disease syndromes and the fall in IMg2+ and [Mg2+]i were found. The ICa2+/IMg2+ ratio appears, from our data, to be an important guide for signs of peripheral vasoconstriction, ischemia or spasm and possibly atherogenesis. Overall, our data point to important uses for ISE's for IMg2+ in the diagnosis and treatment of disease states.
...
PMID:Role of magnesium in patho-physiological processes and the clinical utility of magnesium ion selective electrodes. 886 38
A diet in line with RDAs is seldom achieved by
IDDM
patients. High post-prandial glucose levels are often attributed to food excess rather than to inadequate insulin doses. Lower dietary CHO with greater fat (in particular SFA) and protein are progressively scheduled instead of increasing insulin units. We studied 194
IDDM
patients (1-23 yr) on a diet conforming to RDAs with a restriction of sucrose and without a quantitative approach and exchange lists of food for one year. The diet consisted of a high intake of starchy foods and vegetables and a restricted amount of animal products. HbA1c mean values of the year were used as an indicator of metabolic control. The mean daily insulin dose was 0.53 U/kg in patients with diabetes duration (DD) < 2 yr and 0.81 U/kg in those with DD > 2 yr. Mean annual HbA1c was 7.1 +/- 0.9%. The prevalence of obesity was low (5.7%). Adolescent females were more obese than males. A dietary approach in line with
RDA
requirements, that may help prevent any complications related to an inappropriate diet pattern, coupled with a dynamic insulin adjustment, is the first-line intervention to prevent complications in
IDDM
patients.
...
PMID:Recommended dietary allowances (RDA) in the dietary management of children and adolescents with IDDM: an unfeasible target or an achievable cornerstone? 964 64
Objective:
The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists (AACE), The Obesity Society, American Society of Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists Boards of Directors in adherence with the AACE 2017 protocol for standardized production of CPGs, algorithms, and checklists.
Methods:
Each recommendation was evaluated and updated based on new evidence from 2013 to the present and subjective factors provided by experts.
Results:
New or updated topics in this CPG include: contextualization in an adiposity-based chronic disease complications-centric model, nuance-based and algorithm/checklist-assisted clinical decision-making about procedure selection, novel bariatric procedures, enhanced recovery after bariatric surgery protocols, and logistical concerns (including cost factors) in the current health-care arena. There are 85 numbered recommendations that have updated supporting evidence, of which 61 are revised and 12 are new. Noting that there can be multiple recommendation statements within a single numbered recommendation, there are 31 (13%) Grade A, 42 (17%) Grade B, 72 (29%) Grade C, and 101 (41%) Grade D recommendations. There are 858 citations, of which 81 (9.4%) are evidence level (EL) 1 (highest), 562 (65.5%) are EL 2, 72 (8.4%) are EL 3, and 143 (16.7%) are EL 4 (lowest).
Conclusion:
Bariatric procedures remain a safe and effective intervention for higher-risk patients with obesity. Clinical decision-making should be evidence based within the context of a chronic disease. A team approach to perioperative care is mandatory, with special attention to nutritional and metabolic issues.
A1C
= hemoglobin A1c;
AACE
= American Association of Clinical Endocrinologists;
ABCD
= adiposity-based chronic disease;
ACE
= American College of Endocrinology;
ADA
= American Diabetes Association;
AHI
= Apnea-Hypopnea Index;
ASA
= American Society of Anesthesiologists;
ASMBS
= American Society of Metabolic and Bariatric Surgery;
BMI
= body mass index;
BPD
= biliopancreatic diversion;
BPD/DS
= biliopancreatic diversion with duodenal switch;
CI
= confidence interval;
CPAP
= continuous positive airway pressure;
CPG
= clinical practice guideline;
CRP
= C-reactive protein;
CT
= computed tomography;
CVD
= cardiovascular disease;
DBCD
= dysglycemia-based chronic disease;
DS
= duodenal switch;
DVT
= deep venous thrombosis;
DXA
= dual-energy X-ray absorptiometry;
EFA
= essential fatty acid;
EL
= evidence level;
EN
= enteral nutrition;
ERABS
= enhanced recovery after bariatric surgery;
FDA
= U.S. Food and Drug Administration;
G4G
= Guidelines for Guidelines;
GERD
= gastroesophageal reflux disease;
GI
= gastrointestinal;
HCP
= health-care professional(s);
HTN
= hypertension;
ICU
= intensive care unit;
IGB
= intragastric balloon(s);
IV
= intravenous;
LAGB
= laparoscopic adjustable gastric band;
LAGBP
= laparoscopic adjustable gastric banded plication;
LGP
= laparoscopic greater curvature (gastric) plication;
LRYGB
= laparoscopic Roux-en-Y gastric bypass;
LSG
= laparoscopic sleeve gastrectomy;
MetS
= metabolic syndrome;
NAFLD
= nonalcoholic fatty liver disease;
NASH
= nonalcoholic steatohepatitis;
NSAID
= nonsteroidal anti-inflammatory drug;
OA
= osteoarthritis;
OAGB
= one-anastomosis gastric bypass;
OMA
= Obesity Medicine Association;
OR
= odds ratio;
ORC
= obesity-related complication(s);
OSA
= obstructive sleep apnea;
PE
= pulmonary embolism;
PN
= parenteral nutrition;
PRM
= pulmonary recruitment maneuver;
RCT
= randomized controlled trial;
RD
= registered dietician;
RDA
= recommended daily allowance;
RYGB
= Roux-en-Y gastric bypass;
SG
= sleeve gastrectomy;
SIBO
= small intestinal bacterial overgrowth;
TOS
= The Obesity Society;
TSH
= thyroid-stimulating hormone;
T1D
=
type 1 diabetes
;
T2D
= type 2 diabetes;
VTE
= venous thromboembolism;
WE
= Wernicke encephalopathy;
WHO
= World Health Organization.
...
PMID:CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
EXECUTIVE SUMMARY
. 3168 18